Delivery Order SPE2DB22D3301-SPE2DB26FX3VK
Award Date 10/24/25
Potential Completion Date 10/27/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $7,307.89 to AmerisourceBergen Drug Corp for Fycompa 0.5 mg/ml oral suspension (340ml) on July 18, 2025. This is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, with performance to occur at the contractor's location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 14, 2025, valued at $1,489.87 for the supply of Fycompa 2 mg tablets (30-count packages) under a firm fixed price contract. This is a non-set-aside, competitively awarded delivery order issued by the Defense Logistics Agency's Medical Supply Chain, a component of the Department of Defense. The place of performance is listed as the contractor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,090.14 to AmerisourceBergen Drug Corp for Fycompa 10 mg tablets (30-count package) on August 7, 2025, with completion targeted for August 8, 2025. This firm fixed-price delivery order represents a non-competitive award executed under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Fycompa (perampanel) 0.5 mg/ml oral suspension in a 340ml unit, with a ceiling value of $3,176.22. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. Performance will be completed by July 15, 2025, with the place of performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Fycompa is...
- The Defense Logistics Agency awarded a delivery order valued at $1,580.41 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fycompa 8 mg tablets (30-count packages). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and a completion date of July 22, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's place of performance. This...
- The Defense Logistics Agency awarded a $1,081.20 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Fycompa 8 mg tablets (30-count packaging). This delivery order, which serves as a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA, is scheduled for completion by October 28, 2025, and represents part of the company's ongoing pharmaceutical distribution services to federal healthcare systems. The award was...
- The Defense Logistics Agency awarded a delivery order valued at $2,111.20 to AmerisourceBergen Drug Corp for the supply of Fycompa 4 mg tablets (30-count units) on July 10, 2025, with completion scheduled for July 11, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and was performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of FYCOMPA 8 mg tablets (30-count packages) with a ceiling value of $1,078.18. This firm fixed-price delivery order, with an ultimate completion date of October 28, 2025, represents a competitive award with no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and falls under the company's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Fycompa 6 mg tablets (30-count packaging) under a firm fixed-price contract valued at $2,040.50. This non-set-aside, competitively awarded delivery order has an ultimate completion date of November 3, 2025, and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor for federal medical procurement. The work will be performed at the company's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 21, 2025, for the supply of Fycompa 2 mg tablets (30-count units) valued at $1,493.69. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of July 22, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support...